Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of prophylactic minocycline versus reactive management of cetuximab-induced dermatological toxicity in metastatic colorectal cancer
2011-000877-29Phase 3Completed
- Sponsor
- Grupo de Estudos Oncológicos
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of minocycline in metastatic colorectal adenocarcinoma (mCRC) (2 arms), sponsored by Grupo de Estudos Oncológicos. Started May 2011; status: completed.
02
Drugs
minocycline
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)
Beyond the preview
Go deeper on 2011-000877-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000877-29.